NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Characterization of Methylation Patterns in Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- N/A
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies
- Status
- TERMINATED
- Phase
- NA
Hepatocellular Carcinoma Surveillance in Cirrhotics
- Status
- COMPLETED
- Phase
- NA
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
BioPearlâ„¢ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.
- Status
- WITHDRAWN
- Phase
- NA
DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Longitudinal Immune-phenotyping of HCC Following MK-3475
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
- Status
- UNKNOWN
- Phase
- N/A
Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C
- Status
- UNKNOWN
- Phase
- N/A
Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence
- Status
- UNKNOWN
- Phase
- PHASE2
Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway
- Status
- UNKNOWN
- Phase
- N/A